Mark F. McCarty. 2015. “Flavones and Flavonols May Have Clinical Potential As CK2 Inhibitors in Cancer Therapy”. Cancer Studies and Molecular Medicine 2 (1):39-51. https://doi.org/10.17140/CSMMOJ-2-105.